Allogeneic bone marrow transplant recipients are prone to pulmonary infecti
ons caused by a wide spectrum of organisms. Since the first bone marrow tra
rnsplatation (BMT) done in 1983 at the Tate Memorial Hospital, we have rece
ntly seen the first case of Mycobacterium Fortuitum Chelonae complex among
117 BMT (including 90 allogeneic and 27 autologous) patients. The patient w
as on immunosuppressants for chronic GVHD post allogeneic BMT done for CML-
CP. He developed pulmonary mycobacterial infection 13 months post BMT. Diag
nosis was difficult because of the atypical presentation. negative culture
reports. and the presence of multiple pathogens due to immunosuppression. I
n our case the diagnosis was eventually established after examination of ma
terial obtained by bronchoscopy. Patient has shown response to antitubercul
osis drugs after 2 months. This shows the need to consider atypical mycobac
terial infection in the differential diagnosis of pulmonary illness in the
post allogeneic BMT setting.